Joseph B. Saluri's most recent trade in Zevra Therapeutics Inc was a trade of 39,200 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 25, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zevra Therapeutics Inc | Joseph B. Saluri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2023 | 39,200 | 39,200 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Joseph B. Saluri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Joseph B. Saluri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) |